StockWatch
·
Medical/Nursing Services
Quarterly ResultMay 8, 2026, 04:27 PM

Airsculpt Q1 Net Loss Narrows to $2.4M; Raises $14.6M from Offering

AI Summary

Airsculpt Technologies reported a net loss of $2.4 million for Q1 2026, an improvement from $2.8 million in Q1 2025, with revenue remaining flat at $39.4 million. The company significantly increased its cash and cash equivalents to $16.7 million and reduced total liabilities. This was partly driven by net proceeds of $14.6 million from an at-the-market common stock offering and a $10.0 million voluntary prepayment of its term loan.

Key Highlights

  • Net loss narrowed to $2.4 million in Q1 2026 from $2.8 million in Q1 2025.
  • Revenue remained flat at $39.4 million for Q1 2026 compared to Q1 2025.
  • Basic loss per share improved to $(0.03) in Q1 2026 from $(0.05) in Q1 2025.
  • Net cash provided by operating activities increased to $5.3 million in Q1 2026 from $0.9 million in Q1 2025.
  • Cash and cash equivalents rose to $16.7 million as of March 31, 2026, from $8.4 million at December 31, 2025.
  • Received $14.6 million in net proceeds from an at-the-market common stock offering in Q1 2026.
  • Voluntarily prepaid $10.0 million of the term loan principal during Q1 2026.
  • Total liabilities decreased to $91.7 million as of March 31, 2026, from $99.6 million at December 31, 2025.